Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298571 · ClinicalTrials.gov registry record · Phase 2
Cesarean Delivery and Post-operative Pain Management With Local Anesthesia
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00298571 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 100 participants.
The verdict
NCT00298571, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The use of .5% Bupivacaine with epinephrine at the time of skin closure in cesarean deliveries will decrease post-op pain.
Interventions
- DRUG .5% bupivacaine with epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00298571
The ClinicalTrials.gov registry entry for NCT00298571 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which .5% bupivacaine with epinephrine is the first listed.
NCT00298571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00298571 about?
NCT00298571 is a clinical study titled "Cesarean Delivery and Post-operative Pain Management With Local Anesthesia". The use of .5% Bupivacaine with epinephrine at the time of skin closure in cesarean deliveries will decrease post-op pain.
What is the current status of trial NCT00298571?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2006-02. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00298571?
The interventions under investigation include: .5% bupivacaine with epinephrine (DRUG).
Who is sponsoring clinical trial NCT00298571?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.